Electronic Informed Consent (eConsent)
Electronic informed consent, or eConsent, has become a fixture of modern clinical trials, changing how participants receive information, understand it, and record their agreement to take part.
The shift is not simply paper to screen. Done properly it improves the participant experience and the operational efficiency of the trial at the same time.
What eConsent is
eConsent uses electronic media to present clear, interactive, comprehensible information about a study to potential participants, then documents their consent electronically. The regulatory intent behind informed consent has always been comprehension rather than a signature. Electronic delivery is simply better at producing comprehension.
What it improves
Participant understanding
Using multimedia formats such as explanatory video, interactive graphics and tailored educational modules, eConsent measurably improves how well participants understand the trial’s objectives, risks, benefits and procedures. Some implementations add comprehension checks, so you learn that a participant misunderstood a risk before they enrol rather than after.
Accessibility
Participants can review study information at any time and from anywhere, which makes the process more flexible and better adapted to their individual circumstances. For decentralised and hybrid trials this is not a convenience, it is what makes remote enrolment possible at all.
Regulatory traceability
eConsent provides complete traceability, recording and auditing every interaction a participant has with the consent material. That supports rigorous compliance with ethical and regulatory requirements, including FDA 21 CFR Part 11 and, for European sites, GDPR.
Fewer errors
Digitising the process substantially reduces the errors common to paper consent, such as incomplete forms or missing signatures, and streamlines the overall workflow. A form that cannot be submitted incomplete eliminates an entire category of protocol deviation.
Integrating with a CTMS
Connecting eConsent to a CTMS adds operational benefits beyond the consent process itself.
- Centralised management. Consent data synchronises automatically with the CTMS, which centralises participant information and allows real-time monitoring of consent status across sites.
- Better oversight. Study managers can supervise trial progress and regulatory compliance, and identify problems or areas for improvement quickly rather than at the next monitoring visit.
- Lower administrative load. Removing physical documentation reduces administrative burden and frees study resources.
This matters most around re-consent. When a protocol amendment requires participants to consent again, an integrated system tells you immediately who has and who has not. A paper process tells you weeks later.
In practice
Implementing eConsent is a meaningful step towards modernising informed consent, improving both the participant experience and the operational efficiency of the study.
Integrated effectively with a CTMS it maximises those benefits, upholds high ethical and regulatory standards, and makes trial management more efficient. See how it fits alongside the other clinical trial systems, or get in touch.